Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes

Virology Journal

Volumn 9, Issue , 2012, Pages

  Gyöngyösi, Eszter ^a   Szalmás, Anita ^a   Ferenczi, Annamária ^a   Kónya, József ^a   Gergely, Lajos ^a   Veress, György ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

HPV 16; Involucrin; Keratinocyte differentiation; Oncogenes

Indexed keywords

CALCIUM; INVOLUCRIN; MESSENGER RNA; ONCOPROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; PROTEIN E7; PROTEIN PRECURSOR; REPRESSOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; ONCOGENE; PREPUCE; PROMOTER REGION; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL CULTURE; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN PRECURSORS; REPRESSOR PROTEINS;

EID: 84858076270     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-36     Document Type: Article

References (38)

1. zur Hausen H: Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996, 1288:F55-F78.
2. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324:17-27. (Pubitemid 38737395)
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265. (Pubitemid 34293391)
4. Munger K, Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res 2002, 89:213-228. (Pubitemid 35351540)
5. Mantovani F, Banks L: The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001, 20:7874-7887. (Pubitemid 33135314)
6. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20:7888-7898. (Pubitemid 33135315)
7. Longworth MS, Laimins LA: Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004, 68:362-372. (Pubitemid 38756870)
8. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT: Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev 1995, 9:2335-2349.
9. Jones DL, Alani RM, Munger K: The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 1997, 11:2101-2111. (Pubitemid 27369104)
10. Pei XF, Sherman L, Sun YH, Schlegel R: HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium. Carcinogenesis 1998, 19:1481-1486. (Pubitemid 28409848)
11. Sherman L, Schlegel R: Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J Virol 1996, 70:3269-3279. (Pubitemid 26121948)
12. Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L: Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 2009, 383:69-77.
13. Duffy CL, Phillips SL, Klingelhutz AJ: Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology 2003, 314:196-205. (Pubitemid 37153310)
14. Lehr E, Brown DR: Infection with the oncogenic human papillomavirus type 59 alters protein components of the cornified cell envelope. Virology 2003, 309:53-60. (Pubitemid 36506590)
15. Lehr E, Hohl D, Huber M, Brown D: Infection with Human Papillomavirus alters expression of the small proline rich proteins 2 and 3. J Med Virol 2004, 72:478-483. (Pubitemid 38133990)
16. Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF: Involucrin-structure and role in envelope assembly. J Invest Dermatol 1993, 100:613-617.
17. Rose BR, Thompson CH, Tattersall MH, Elliott PM, Dalrymple C, Cossart YE: Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction. Gynecol Oncol 1995, 56:239-244.
18. Howie HL, Katzenellenbogen RA, Galloway DA: Papillomavirus E6 proteins. Virology 2009, 384:324-334.
19. Liu X, Roberts J, Dakic A, Zhang Y, Schlegel R: HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function. Virology 2008, 375:611-623.
20. Santin AD, Zhan F, Bignotti E, Siegel ER, Cane S, Bellone S, Palmieri M, Anfossi S, Thomas M, Burnett A, et al: Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005, 331:269-291. (Pubitemid 40075455)
21. Wong YF, Cheung TH, Tsao GS, Lo KW, Yim SF, Wang VW, Heung MM, Chan SC, Chan LK, Ho TW, et al: Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 2006, 118:2461-2469.
22. Kravchenko-Balasha N, Mizrachy-Schwartz S, Klein S, Levitzki A: Shift from apoptotic to necrotic cell death during human papillomavirus-induced transformation of keratinocytes. J Biol Chem 2009, 284:11717-11727.
23. Wan F, Miao X, Quraishi I, Kennedy V, Creek KE, Pirisi L: Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer 2008, 123:32-40. (Pubitemid 351705189)
24. Zhang B, Chen W, Roman A: The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA 2006, 103:437-442. (Pubitemid 43122419)
25. Rossi A, Jang SI, Ceci R, Steinert PM, Markova NG: Effect of AP1 transcription factors on the regulation of transcription in normal human epidermal keratinocytes. J Invest Dermatol 1998, 110:34-40. (Pubitemid 28086060)
26. Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, Bone F, Adhikary G, Huang G, Gopalakrishnan R, Balasubramanian S: Regulation of involucrin gene expression. J Invest Dermatol 2004, 123:13-22. (Pubitemid 38833458)
27. Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T: Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 2007, 27:3732-3742. (Pubitemid 46726180)
28. Welter JF, Crish JF, Agarwal C, Eckert RL: Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J Biol Chem 1995, 270:12614-12622.
29. Eckert RL, Crish JF, Banks EB, Welter JF: The epidermis: genes on-genes off. J Invest Dermatol 1997, 109:501-509.
30. Mehic D, Bakiri L, Ghannadan M, Wagner EF, Tschachler E: Fos and jun proteins are specifically expressed during differentiation of human keratinocytes. J Invest Dermatol 2005, 124:212-220. (Pubitemid 40100971)
31. Wise-Draper TM, Allen HV, Thobe MN, Jones EE, Habash KB, Munger K, Wells SI: The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J Virol 2005, 79:14309-14317. (Pubitemid 41552728)
32. Wise-Draper TM, Mintz-Cole RA, Morris TA, Simpson DS, Wikenheiser- Brokamp KA, Currier MA, Cripe TP, Grosveld GC, Wells SI: Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo. Cancer Res 2009, 69:1792-1799.
33. McCloskey R, Menges C, Friedman A, Patel D, McCance DJ: Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation. J Virol 2010, 84:5131-5139.
34. Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ: The human papillomavirus type 16 E7 gene product interacts with and transactivates the AP1 family of transcription factors. EMBO J 1996, 15:1950-1960. (Pubitemid 26119228)
35. Ng DC, Shafaee S, Lee D, Bikle DD: Requirement of an AP-1 site in the calcium response region of the involucrin promoter. J Biol Chem 2000, 275:24080-24088.
36. Armstrong DJ, Roman A: The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Virology 1997, 239:238-246. (Pubitemid 28027087)
37. Murvai M, Borbély AA, Kónya J, Gergely L, Veress G: Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter. Arch Virol 2004, 149:2379-2392. (Pubitemid 40059337)
38. Borbély AA, Murvai M, Kónya J, Beck Z, Gergely L, Li F, Veress G: Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol 2006, 87:287-294. (Pubitemid 43169253)